NTCOC
LFCR icon

Northern Trust Company of Connecticut’s Lifecore Biomedical LFCR Stock Holding History

Northern Trust Company of Connecticut’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$567K Buy
46,800
+15,750
+51% +$188K ﹤0.01% 1532
2013
Q3 		$379K Buy
31,050
+18,350
+144% +$256K ﹤0.01% 1597
2013
Q2 		$168K Buy
+12,700
New +$176K ﹤0.01% 1737

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Northern Trust Company of Connecticut's LFCR Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Lifecore Biomedical (LFCR) stake by 51% in Q4 2013, buying an estimated $188K and bringing the position to 46,800 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Northern Trust Company of Connecticut first reported a position in LFCR in Q2 2013 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold LFCR as of Q4 2013.

  • Northern Trust Company of Connecticut held 46,800 shares of Lifecore Biomedical worth $567K as of Q4 2013.
  • Northern Trust Company of Connecticut bought 15,750 Lifecore Biomedical shares in Q4 2013, an estimated $188K.
  • Lifecore Biomedical made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1532 holding.
  • Northern Trust Company of Connecticut first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.